免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

LigaPASS™ 系統

K 號:K261374 · 2026-05-27

決定日期2026-05-27
產品代碼OWI
諮詢委員會或
決定相當於

器材摘要

LigaPASS™ System is the device name listed in this FDA 510(k) record. The listed applicant is Medicrea International S.A.S. It received FDA 510(k) clearance on 2026-05-27 under 510(k) number K261374. The device is classified under product code OWI. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the LigaPASS™ System?

LigaPASS™ System is a medical device that received FDA 510(k) clearance on 2026-05-27. The listed applicant is Medicrea International S.A.S. The 510(k) number is K261374.

When did LigaPASS™ System receive FDA 510(k) clearance?

LigaPASS™ System received FDA 510(k) clearance on 2026-05-27, under 510(k) number K261374.

Who is the listed applicant for LigaPASS™ System?

The FDA 510(k) record lists Medicrea International S.A.S as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LigaPASS™ System?

The FDA product code for LigaPASS™ System is OWI.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:OWI)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑